logo

Bausch Health Companies Inc. (BHC)



Trade BHC now with
  Date
  Headline
12/12/2018 6:32:07 AM Bausch Health To Acquire Substantially All The Assets Of Synergy Pharmaceuticals
12/5/2018 8:06:38 AM Bausch + Lomb Gets 510(K) Clearance From FDA For Bausch + Lomb Ultra Multifocal For Astigmatism Contact Lense
12/5/2018 8:03:41 AM Bausch + Lomb Secures 510(K) Clearance From FDA For Ultra Multifocal For Astigmatism Contact Lenses
11/30/2018 8:58:56 AM Bausch Health Plans Redemption Of $200 Mln Of 5.625% Senior Notes Due 2021
11/7/2018 7:18:56 AM Bausch Health Unveils U.S. Launch Of BRYHALI Lotion, 0.01%, For Plaque Psoriasis In Adults
11/6/2018 7:10:27 AM Bausch Health Companies Q3 Net Loss $350 Mln Vs Net Income $1.301 Bln Last Year
10/30/2018 8:07:46 AM Bausch Health Unveils Launch Of ALTRENO Lotion, 0.05% In The U.S.
10/24/2018 8:06:28 AM Bausch + Lomb To Launch Surgical Support Applications For Stellaris Elite Vision Enhancement System On IBM Cloud
10/11/2018 8:02:30 AM Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO Lotion
10/8/2018 7:06:30 AM Bausch Health's BRYHALI Lotion, 0.01%, Gets Tentative FDA Approval For Plaque Psoriasis In Adults
10/2/2018 7:03:34 AM Ortho Dermatologics Publishes Pivotal Phase 3 Safety Data On Bryhali Lotion In Ournal Of Drugs In Dermatology
9/27/2018 7:49:05 AM Dova Pharma And Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET
9/12/2018 7:08:33 AM Bausch Health Unveils Resolution Of XIFAXAN Intellectual Property Litigation
8/29/2018 7:04:09 AM Ortho Dermatologics: FDA Accepts Resubmission Of NDA For Duobrii™1 Lotion; PDUFA Action Date Set For February 15
8/24/2018 10:26:43 AM Ortho Dermatologics Receives FDA Approval For ALTRENO Lotion For Acne